 BERWYN, Pa.--BUSINESS WIRE-- pharma--Virpax Pharmaceuticals Inc. Virpax or the Company NASDAQ:VRPX, a company specializing in developing pharmaceutical products for pain management, today announced the pricing of an underwritten public offering of 6,670,000 shares of its common stock at a public offering price of 6.00 per share, for gross proceeds of 40,020,000 million, before deducting underwriting discounts and offering expenses. In addition, Virpax has granted the underwriters a 45-day o 